Dyadic International (DYAI) Change in Acquisitions & Divestments (2018 - 2026)
Dyadic International (DYAI) posted Change in Acquisitions & Divestments of $1.8 million for Q1 2026, up 37.84% sequentially from $1.3 million in Q4 2025, and down 5.58% YoY from $1.9 million in Q1 2025.
Dyadic International (DYAI) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Dyadic International has reported Change in Acquisitions & Divestments for 9 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 5.58% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 8.08% YoY) and the FY2025 annual result came in at $6.0 million, up 11.62% from the prior year.
- Change in Acquisitions & Divestments climbed to $1.8 million in Q1 2026 per DYAI's latest filing, from $1.3 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $4.5 million in Q1 2022 and troughed at $624010.0 in Q3 2025.
- A 5-year average of $1.9 million and a median of $1.9 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments sank 99.92% in 2022, then surged 281.0% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $2.0 million in 2022, then tumbled by 61.25% to $775000.0 in 2023, then jumped by 240.0% to $2.6 million in 2024, then tumbled by 49.54% to $1.3 million in 2025, then soared by 37.84% to $1.8 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.8 million, $1.3 million, and $624010.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 624,010.00 |
| Sep 30, 2025 | 624,010.00 |
| Jun 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.94 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 646,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 775,000.00 |
| Dec 31, 2023 | 775,000.00 |